Do you want to read an article? Please log in or register.
The effect of medical treatments on the bacterial microbiome in patients with chronic rhinosinusitis: a pilot study
Respiratory Tract Infection
Related content
Respiratory Tract Infection
A cost-effectiveness analysis of the up-front use of balloon catheter dilation in the treatment of pediatric chronic rhinosinusitis
Am J Otolaryngol.
House LK, Lewis AF, Ashmead MG
doi: 10.1016/j.amjoto.2018.04.007.
RECOMMENDED
COPD
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: a post-hoc analysis of the PANTHEON study
Respir Med.
Papi A, Zheng J, Criner GJ,
Fabbri LM, Calverley P
doi: 10.1016/j.rmed.2018.12.014.
Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
NPJ Prim Care Respir Med.
Ferguson GT, Karpel J, Bennett N, Clerisme-Beaty E, Grönke L, Voß F, Buhl R
doi: 10.1038/s41533-016-0002-x.
RECOMMENDED
COPD
Effect of nocturnal EPAP titration to abolish tidal expiratory flow limitation in COPD patients with chronic hypercapnia: a randomized, cross-over pilot study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Zannin E, Milesi I, Porta R, Cacciatore S, Barbano L, Trentin R, Fanfulla F, Vitacca M, Dellacà RL
doi: 10.1186/s12931-020-01567-x
Further Publications
Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review
Rhinology.
Tsetsos N, Goudakos JK, Daskalakis D, Konstantinidis I, Markou K
doi: 10.4193/Rhin17.156.
COMMENTED
Feasibility, acceptability and effectiveness of integrated care for COPD patients: a mixed methods evaluation of a pilot community-based programme
Swiss Med Wkly.
Carron T, Bridevaux PO, Lörvall K, Parmentier R, Moix JB, Beytrison V, Pernet R, Rey C, Roberfroid PY, Chhajed PN, Dieterle T, Joos Zellweger L, Kohler M, Maier S, Miedinger D, Thurnheer R, Urwyler P, Tschopp JM, Zuercher E, Leuppi JD, Burnand B, Peytremann-Bridevaux I
doi: 10.4414/smw.2017.14567.
RECOMMENDED
COPD
Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups
Respir Med.
Bakerly ND, Woodcock A,
Collier S, Leather DA, New JP,
Crawford J, Harvey C, Vestbo J,
Boucot I
doi: 10.1016/j.rmed.2018.12.016.
RECOMMENDED
COPD
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
Lancet Respir Med.
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/S2213-
RECOMMENDED
Asthma
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Crimi C, Campisi R, Nolasco S, Cacopardo G, Intravaia R, Porto M, Impellizzeri P, Pelaia C, Crimi N
doi: 10.1016/j.rmed.2021.106491